CryoPort, Inc. Common Stock
CYRXCryoPort, Inc. (CYRX) specializes in temperature-controlled supply chain solutions for the transportation and storage of biotech and pharmaceutical products. The company provides cryogenic shipping services using its proprietary CryoPort Express platform, ensuring the safe and reliable movement of sensitive biologics, vaccines, and cell therapies worldwide.
Company News
Cryoport Systems has become the first global supply chain solutions company to achieve ISO 21973 certification, demonstrating its leadership in ensuring safe and traceable transportation of cell and gene therapies.
Cryoport Systems has launched a new 55,000-square-foot global supply chain center near Paris, France, expanding its network to support complex life sciences supply chain needs, including biologistics and bioservices.
The global clinical trial biorepository and archiving solutions market is projected to grow from USD 4.76 billion in 2025 to USD 9.69 billion by 2034, with a CAGR of 8.21%. North America dominates the market, while Asia Pacific is expected to experience the fastest growth, driven by advancements in biobanking technologies and increasing demand fo...
Cryoport CEO Jerrell Shelton exercised and sold 16,344 shares at $7.06 per share, retaining 928,763 shares. The company continues to face financial challenges with recent revenue drops and ongoing losses.
Cryoport, a global provider of supply chain solutions for the life sciences sector, will report its first quarter 2025 financial results on May 7, 2025. The company will host a conference call to discuss the results.
